Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma-Reference-Cited by-同舟云学术

Evaluation of a miRNA-371a-3p Assay for Predicting Final Histopathology in Patients Undergoing Primary Nerve-sparing Retroperitoneal Lymphadenectomy for Stage IIA/B Seminoma or Nonseminoma

Published:2023-11 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Seelemeyer Felix,Pfister David,Pappesch Robert,Merkelbach-Bruse Sabine,Paffenholz Pia,Heidenreich Axel^ORCID

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference17 articles.

1. Testicular cancer: epidemiology, diagnosis, and management;Smith;Med Clin North Am,2018

2. European Association of Urology guidelines on testicular cancer: 2023 update;Patrikidou;Eur Urol,2023

3. American Urological Association. Testicular cancer guidelines. American Urological Association Web site. http://www.auanet.org/guidelines-and-quality/guidelines/oncology-guidelines/testicular-cancer.

4. Heidenreich A, Paffenholz P, Hartmann F, Seelemeyer F, Pfister D. Retroperitoneal lymph node dissection in clinical stage IIA/N metastatic seminoma. Results of the Cologne trial of retroperitoneal lymphadenectomy in metastatic seminoma (COTRIMS). Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.06.004.

5. Phase 2 single-arm trial of primary retroperitoneal lymph node dissection in patients with seminomatous testicular germ cell tumors with clinical stage IIA/B (PRIMETEST);Hiester;Eur Urol,2023

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Die primäre retroperitoneale Lymphadenektomie beim testikulären Keimzelltumor im klinischen Stadium IIA/B – Renaissance einer etablierten Therapie?;Die Urologie;2024-09-13

2. Long-term clinical outcomes of patients with negative pathology (pN0) at primary retroperitoneal lymph node dissection;Clinical Genitourinary Cancer;2024-09

3. Hodentumor – welche Vorteile bringt der neue Tumormarker microRNA-371a-3p (M371-Test);Aktuelle Urologie;2024-08-12

4. Seminom im klinischen Stadium IIA/B – machen oder nicht machen: welchen Stellenwert hat die retroperitoneale Lymphadenektomie?;Aktuelle Urologie;2024-08-01

5. Regionalization of Testis Cancer Care—Is It Necessary?;Urologic Clinics of North America;2024-08